SMA is a genetic condition that impacts motor neurons, leading to muscle weakness that affects essential functions like breathing and movement. Treatments like Spinraza and Zolgensma can help manage ...

Spinal muscular atrophy (SMA) is a rare genetic condition that impairs a person’s ability to control their muscle movement. Most types of SMA are diagnosed in infants, but the condition sometimes ...

Spinal muscular atrophy (SMA) is a genetic neuromuscular condition caused by mutations in the SMN1 gene. SMA is characterized by symmetrical progressive (proximal predominant) muscle atrophy caused by ...

Authors of a systematic literature review concluded more research is needed to better understand the financial burden of spinal muscular atrophy (SMA). More robust, long-term studies are needed to ...

As the feasibility of phase 1 clinical trials for prenatal spinal muscular atrophy (SMA) therapies is explored, patient and parent input on prenatal testing and possibly treatment is a valuable tool ...

SMA, which can affect up to 10,000 children around the world, comes under four main types: Types 1, 2 and 3 appear in childhood; Type 4, also known as adult-onset SMA, appears in adulthood. SMA Type 1 ...

Whole-body quantitative MRI, or qMRI, was found to detect subtle changes over time in the muscles of SMA adults, better than clinical tests.